ArticleArchives of dermatological research2024
Experience of negative pressure fractional microneedle radiofrequency therapy for axillary osmidrosis: a case study.
Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNegative pressure fractional microneedle radiofrequency (NPFMR) therapy has emerged as a potential minimally invasive treatment for axillary osmidrosis (AO), a condition characterized by persistent strong body odor from the armpit area.
methodsThis case study aims to assess the efficacy and safety of NPFMR for AO treatment. From January to September 2024, 30 patients with AO were recruited, with a gender distribution of 19 females and 11 males, aged 17-34 years (mean 23). AO was diagnosed based on the presence of strong armpit odor in the absence of significant hyperhidrosis. The severity of AO was classified into four grades. All patients were followed up at 3 months, 6 months and 1 year post-treatment. The efficacy and complications were recorded and assessed.
resultsThe efficacy rates observed at 3 months and 6 months post-treatment were 83.67% and 76.67% respectively, with the efficacy rate remaining the same as that at 6 months after 1 year of follow-up. There were four cases of complications, At the 3-month follow-up, three patients developed punctate scars in the treated area, with the largest scar measuring 0.5 cm in diameter. One patient reported a numbness in their upper limb at the 3-month follow-up, which resolved after oral administration of mecobalamin at the 6-month follow-up. The total complication rate for this group was 13.3%.
conclusionNPFMR therapy demonstrates promising short-term efficacy for AO treatment. However, caution should be exercised due to potential complications, and comprehensive patient education is necessary. Longer-term follow-up studies are needed to evaluate the durability of the therapeutic effects and to monitor for any delayed adverse effects. Strategies for managing complications should also be explored to improve patient care outcomes.
Indexed as
Identifiers
39636411What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.